METASTATIC PRIMARY CENTRAL CHONDROSARCOMA
Clinical trials for METASTATIC PRIMARY CENTRAL CHONDROSARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PRIMARY CENTRAL CHONDROSARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC PRIMARY CENTRAL CHONDROSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo targets rare, Tough-to-Treat bone cancer
Disease control OngoingThis study is testing whether a combination of two drugs, belinostat and either guadecitabine or ASTX727, can help control advanced chondrosarcoma, a rare type of bone cancer that cannot be removed by surgery or has spread. The goal is to see if this treatment can shrink tumors o…
Matched conditions: METASTATIC PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC
-
Immune system boost tested against rare, Tough-to-Treat cancers
Disease control OngoingThis study is testing whether a drug called atezolizumab can help control advanced forms of two rare cancers: chondrosarcoma (bone cancer) and clear cell sarcoma (soft tissue cancer). The drug works by helping the patient's own immune system recognize and attack the cancer cells.…
Matched conditions: METASTATIC PRIMARY CENTRAL CHONDROSARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC